Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer (Q45814103)

16 December 2017

title

Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer (English)

1 reference

16 December 2017

1 reference

1 reference

8

Barbara Schmalfeldt

1 reference

16 December 2017

Karin Milde-Langosch

9

object named as

Karin Milde-Langosch

1 reference

16 December 2017

Leticia Oliveira-Ferrer

10

object named as

Leticia Oliveira-Ferrer

1 reference

16 December 2017

author name string

Katharina Prieske

1

1 reference

16 December 2017

Stefan Prieske

2

1 reference

16 December 2017

Simon A Joosse

3

1 reference

16 December 2017

Fabian Trillsch

4

1 reference

16 December 2017

Donata Grimm

5

1 reference

16 December 2017

Eike Burandt

6

1 reference

16 December 2017

Sven Mahner

7

1 reference

16 December 2017

Linn Woelber

11

1 reference

16 December 2017

language of work or name

English

0 references

publication date

15 September 2017

1 reference

16 December 2017

published in

Oncotarget

1 reference

16 December 2017

volume

8

1 reference

16 December 2017

issue

47

1 reference

16 December 2017

page(s)

83063-83074

1 reference

16 December 2017

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Methylation status and immunohistochemistry of BRCA1 in epithelial ovarian cancer

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Integrated genomic analyses of ovarian carcinoma

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

24 May 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Distinct transcription start sites generate two forms of BRCA1 mRNA.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Whole-genome characterization of chemoresistant ovarian cancer.

24 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5669950

Methylation-sensitive DNA binding by v-myb and c-myb proteins

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29137324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29137324

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.20945

1 reference

16 December 2017

release_3nt5ukz33zad7jymes6bphzme4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3nt5ukz33zad7jymes6bphzme4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

5669950

1 reference

16 December 2017

PubMed ID

29137324

1 reference

16 December 2017